PSC
RGNX icon

Prentiss Smith & Co’s Regenxbio RGNX Stock Holding History

Prentiss Smith & Co’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,107
Closed -$181K – 72
2023
Q4 		$181K Sell
10,107
-1,133
-10% -$20K 0.14% 66
2023
Q3 		$185K Buy
+11,240
New +$204K 0.14% 64
2023
Q1 		– Sell
-9,431
Closed -$214K – 68
2022
Q4 		$214K Sell
9,431
-153
-2% -$3.46K 0.19% 59
2022
Q3 		$253K Sell
9,584
-125
-1% -$3.71K 0.22% 55
2022
Q2 		$240K Sell
9,709
-1,000
-9% -$25K 0.19% 61
2022
Q1 		$355K Sell
10,709
-180
-2% -$5K 0.21% 60
2021
Q4 		$356K Sell
10,889
-100
-0.9% -$3.4K 0.17% 67
2021
Q3 		$461K Hold
10,989
– – 0.23% 56
2021
Q2 		$427K Sell
10,989
-117
-1% -$4.18K 0.21% 61
2021
Q1 		$379K Sell
11,106
-670
-6% -$28.6K 0.19% 60
2020
Q4 		$534K Sell
11,776
-625
-5% -$21.8K 0.25% 53
2020
Q3 		$341K Buy
12,401
+18
+0.1% +$587 0.18% 56
2020
Q2 		$456K Buy
12,383
+152
+1% +$5.67K 0.28% 44
2020
Q1 		$396K Buy
12,231
+200
+2% +$8.33K 0.27% 48
2019
Q4 		$493K Buy
12,031
+4,425
+58% +$175K 0.32% 44
2019
Q3 		$271K Buy
7,606
+56
+0.7% +$2.27K 0.18% 54
2019
Q2 		$388K Buy
+7,550
New +$377K 0.25% 53
2018
Q4 		– Sell
-670
Closed -$51K – 191
2018
Q3 		$51K Hold
670
– – 0.03% 117
2018
Q2 		$48K Buy
+670
New +$32K 0.03% 120

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Prentiss Smith & Co's RGNX Position: Q1 2024 in Review

Prentiss Smith & Co sold out of Regenxbio (RGNX) in Q1 2024, closing a stake of 10,107 shares — an estimated $181K sold.

Prentiss Smith & Co first reported a position in RGNX in Q2 2018 and held it in 19 quarters. The position peaked at $534K in Q4 2020. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2024.

  • Prentiss Smith & Co reported no remaining Regenxbio position as of Q1 2024 after selling out during the quarter.
  • Prentiss Smith & Co sold 10,107 Regenxbio shares in Q1 2024, an estimated $181K.
  • Prentiss Smith & Co first reported a position in Regenxbio in Q2 2018 and held it in 19 quarters.
  • Prentiss Smith & Co's Regenxbio position peaked at $534K in Q4 2020.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2024.

Based on Prentiss Smith & Co's 13F filing for Q1 2024, filed 30 Apr 2024.